or Try an Advanced Search...

    Agios Pharmaceuticals Stocks List

    Symbol Grade Name % Change
    AGIO A Agios Pharmaceuticals, Inc. 2.30
    ASLN F ASLAN Pharmaceuticals Limited -11.13
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Acid Biopharmaceutical Biotechnology Cancer Cyclacel Glutamate Hydrogen Inborn Errors Of Metabolism Life Sciences Metabolism Organic Chemistry Pyruvate Kinase Deficiency

    Related ETFs - A few ETFs which own one or more of the above listed Agios Pharmaceuticals stocks.

    Symbol Grade Name Weight
    BBP D BioShares Biotechnology Products Fund 2.58
    WDNA D WisdomTree BioRevolution Fund 1.72
    LABD B Direxion Daily S&P Biotech Bear 3X Shares 1.37
    SBIO D ALPS Medical Breakthroughs ETF 1.09
    XBI D SPDR S&P Biotech ETF 0.78
    View all Agios Pharmaceuticals ETFs...
    Compare ETFs
    Compare BBP to XBI Compare LABD to XBI Compare WDNA to LABD

        Agios Pharmaceuticals Stocks Recent News

        Date Stock Title
        Apr 18 AGIO Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
        Apr 16 AGIO The 3 Best Biotech Stocks to Buy Now: Q2 Edition
        Related Industries: Biotechnology
        Related Stock Lists: Acid Biopharmaceutical Biotechnology Cancer Cyclacel Glutamate Hydrogen Inborn Errors Of Metabolism Life Sciences Metabolism Organic Chemistry Pyruvate Kinase Deficiency
        Agios Pharmaceuticals

        Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

        More about Agios Pharmaceuticals
        Browse All Tags